AR

Anita Rankawat

Active Director Director DIN 11438876
DIN 11438876 First appointment Dec 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Anita Rankawat

Data last updated:

Anita Rankawat is a Director at Hisar Nirog Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11438876
Primary Designation Director
Industry Healthcare
First Appointment 19 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 2025Active

Directorship timeline

Open interactive timeline →
Hisar Nirog Healthcare Private Limited
Premium access

Shareholding and investment profile for Anita Rankawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Rankawat

Anita Rankawat currently holds 1 directorship: Hisar Nirog Healthcare Private Limited (Director, since 19 Dec 2025).

Anita Rankawat was first appointed on 19 Dec 2025 as Director at Hisar Nirog Healthcare Private Limited.

The current boards of Anita Rankawat's companies include Anil Kumar Popli (Hisar Nirog Healthcare Private Limited), Anjali Sharma (Hisar Nirog Healthcare Private Limited), Bharat Kansal (Hisar Nirog Healthcare Private Limited), Gulab Rai Gupta (Hisar Nirog Healthcare Private Limited), Kamal Kishore (Hisar Nirog Healthcare Private Limited), Kuldeep Saharawat (Hisar Nirog Healthcare Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available